258 related articles for article (PubMed ID: 18945310)
1. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature.
Domm S; Cinatl J; Mrowietz U
Br J Dermatol; 2008 Dec; 159(6):1217-28. PubMed ID: 18945310
[TBL] [Abstract][Full Text] [Related]
2. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
Carroll MB; Bond MI
Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
[TBL] [Abstract][Full Text] [Related]
3. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections.
Vassilopoulos D; Calabrese LH
Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544
[TBL] [Abstract][Full Text] [Related]
4. Varicella zoster virus infection in patients taking the TNF-alpha inhibitor, etanercept: coincidence or causal?
Izumi A
Hawaii Med J; 2009 Dec; 68(11):277-8. PubMed ID: 20034255
[TBL] [Abstract][Full Text] [Related]
5. How to manage infections in the era of biologics?
Saraceno R; Chimenti S
Dermatol Ther; 2008; 21(3):180-6. PubMed ID: 18564248
[TBL] [Abstract][Full Text] [Related]
6. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor.
Winthrop KL
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):602-10. PubMed ID: 17075599
[TBL] [Abstract][Full Text] [Related]
7. Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.
Shale MJ; Seow CH; Coffin CS; Kaplan GG; Panaccione R; Ghosh S
Aliment Pharmacol Ther; 2010 Jan; 31(1):20-34. PubMed ID: 19681818
[TBL] [Abstract][Full Text] [Related]
8. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.
Calabrese LH; Zein N; Vassilopoulos D
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii18-ii24. PubMed ID: 15479865
[TBL] [Abstract][Full Text] [Related]
9. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
10. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease.
Shale MJ
Br Med Bull; 2009; 92():61-77. PubMed ID: 19855102
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic T-cell lymphomas and therapy with TNF-alpha-blocking biologics: a risk for psoriasis patients?
Beyer M; Steinhoff M; Anagnostopoulos I; Assaf C; Sterry W
J Dtsch Dermatol Ges; 2009 Mar; 7(3):191-4. PubMed ID: 19192165
[TBL] [Abstract][Full Text] [Related]
12. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.
Theis VS; Rhodes JM
Aliment Pharmacol Ther; 2008 Jan; 27(1):19-30. PubMed ID: 17944997
[TBL] [Abstract][Full Text] [Related]
13. Biologics and infections: lessons from tumor necrosis factor blocking agents.
Wallis RS
Infect Dis Clin North Am; 2011 Dec; 25(4):895-910. PubMed ID: 22054762
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
Baugh JA; Bucala R
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
[TBL] [Abstract][Full Text] [Related]
15. Biomedicines to reduce inflammation but not viral load in chronic HCV--what's the sense?
Chuang E; Del Vecchio A; Smolinski S; Song XY; Sarisky RT
Trends Biotechnol; 2004 Oct; 22(10):517-23. PubMed ID: 15450745
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
[TBL] [Abstract][Full Text] [Related]
17. Potential target of infliximab in autoimmune and inflammatory diseases.
Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P
Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744
[TBL] [Abstract][Full Text] [Related]
18. Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease.
Fiorino G; Allez M; Malesci A; Danese S
Aliment Pharmacol Ther; 2009 May; 29(9):921-7. PubMed ID: 19210297
[TBL] [Abstract][Full Text] [Related]
19. Viral infection in the renal transplant recipient.
Kotton CN; Fishman JA
J Am Soc Nephrol; 2005 Jun; 16(6):1758-74. PubMed ID: 15829710
[TBL] [Abstract][Full Text] [Related]
20. Treatment of inflammatory dermatoses by tumour necrosis factor antagonists.
Jacobi A; Mahler V; Schuler G; Hertl M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1171-87. PubMed ID: 17062028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
